A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by most U.S. states, accusing them of conspiring to fix prices of 80 generic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback